EORTC protocol 22051 - 10052

Selective Use of Postoperative Radiotherapy AftEr MastectOmy (SUPREMO)


Trial web site:
http://www.supremo-trial.com

Trial StatusOpen
DatesDate of activation: 03/10/2006
Data management at EORTCMailbox
Phase3
Randomized trialNo
Type-
Targeted Sample sizeEORTC Groups: 1500 - All Groups: 3700
Number of steps1
DrugCyclophosphamide (CPM)
Prednisone
Study StaffGeertjan Van Tienhoven (Study Coordinator) - Academisch Medisch Centrum, Amsterdam
Laurence Collette (Statistician) - EORTC, Brussels
Livia Giurgea (Data Manager) - EORTC, Brussels
Cecilia Liberatoscioli (Coordinating Physician) - EORTC, Brussels
Nadège Gosselin (Project Manager) - EORTC, Brussels, nadege.gosselin( at )eortc.be, +32 2 7741690
Type of cancerBreast
Participating GroupsScottish Cancer Trials Breast Group(Coordinating Group)
EORTC Breast Cancer Group
EORTC Radiation Oncology Group
Currently authorized centers ZNA Middelheim (Antwerpen, Belgium) - Inst. 114
Hopital De Jolimont (Haine St Paul, Belgium) - Inst. 474
Chr De Grenoble - La Tronche (Grenoble, France) - Inst. 215
Centre Antoine Lacassagne (Nice, France) - Inst. 218
Centre Leon Berard (Lyon, France) - Inst. 227
Centre Georges-Francois-Leclerc (Dijon, France) - Inst. 229
Centre Oscar Lambret (Lille, France) - Inst. 234
Centre Paul Papin (Angers, France) - Inst. 2218
Charite - Universitaetsmedizin Berlin - Campus Mitte (Berlin, Germany) - Inst. 198
Rambam Medical Center (Haifa, Israel) - Inst. 910
Oncology Centre Of Lublin Land (Lublin, Poland) - Inst. 5819
Medical University Of Gdansk (Gdansk, Poland) - Inst. 551
Hospital Clinic Universitari (Barcelona, Spain) - Inst. 369
Hospital General Vall D'Hebron (Barcelona, Spain) - Inst. 371
Hopital Cantonal Universitaire De Geneve (Geneve, Switzerland) - Inst. 451
Centre Hospitalier Universitaire Vaudois (Lausanne, Switzerland) - Inst. 457
Kantonsspital Winterthur (Winterthur, Switzerland) - Inst. 6614
Maastro Clinic - Maastricht Radiation Oncology (Maastricht, The Netherlands) - Inst. 4900
Radiotherapeutisch Instituut Friesland (Leeuwarden, The Netherlands) - Inst. 388
Radiotherapeutisch Instituut Stedendriehoek en Omstreken (Deventer, The Netherlands) - Inst. 300
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, The Netherlands) - Inst. 301
Universitair Medisch Centrum - Academisch Ziekenhuis (Utrecht, The Netherlands) - Inst. 306
Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310
Medisch Centrum Haaglanden - Westeinde (Den Haag, The Netherlands) - Inst. 311
University Medical Center Groningen (Groningen, The Netherlands) - Inst. 335
Dr. Bernard Verbeeten Instituut (Tilburg, The Netherlands) - Inst. 341
Academisch Medisch Centrum (Amsterdam, The Netherlands) - Inst. 342
Arnhem 'S Radiotherapeutisch Instituut (Arnhem, The Netherlands) - Inst. 350
Marmara University Hospital (Istanbul, Turkey) - Inst. 971
Protocol summaryLink provided by NCI PDQ
Back to Protocol section